IPO Timeline
Broker Results (T-2)
2024-10-04
Some brokers release in afternoon
Grey Market (T-1)
2024-10-07
Afternoon
HKEX Allotment (T-1)
2024-10-07
Evening
Registrar Allotment (T-1)
2024-10-07
Evening
Listing Day (T)
2024-10-08
First day of trading
Company Overview
| Stock Name | 太美医疗科技 |
|---|---|
| Stock Code | 02576 |
| Company Full Name | 太美医疗科技 |
| Industry | 軟件服務 |
| Principal Activities | 公司是中國醫藥及醫療器械研發和營銷領域最大的數字化解決方案供應商，為醫藥及醫療器械行業的產業鏈各方設計并提供專業的軟件及數字化服務。 |
| Listing Date | 2024-10-08 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國浙江省嘉興市昌盛南路36號智慧產業創新園9號樓3樓 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | https://www.taimei.com/ |
| Share Registrar | 卓佳证券登记有限公司 (Tricor Investor Services Limited) |
| Registrar Contact | (852)2862 8628 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 13.00 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 0% |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 167,564,800 |
Subscription Tiers
Minimum subscription unit: 1 lot. Subscription amount ≤ HK$5,000,000 is Pool A, > HK$5,000,000 is Pool B.
Pool A
| Lots Subscribed | Shares Subscribed | Subscription Amount (HKD) |
|---|---|---|
| 1 lots | 200 | HK$ 2,600 |
| 2 lots | 400 | HK$ 5,200 |
| 3 lots | 600 | HK$ 7,800 |
| 4 lots | 800 | HK$ 10,400 |
| 5 lots | 1,000 | HK$ 13,000 |
| 6 lots | 1,200 | HK$ 15,600 |
| 7 lots | 1,400 | HK$ 18,200 |
| 8 lots | 1,600 | HK$ 20,800 |
| 9 lots | 1,800 | HK$ 23,400 |
| 10 lots | 2,000 | HK$ 26,000 |
| 15 lots | 3,000 | HK$ 39,000 |
| 20 lots | 4,000 | HK$ 52,000 |
| 25 lots | 5,000 | HK$ 65,000 |
| 30 lots | 6,000 | HK$ 78,000 |
| 35 lots | 7,000 | HK$ 91,000 |
| 40 lots | 8,000 | HK$ 104,000 |
| 45 lots | 9,000 | HK$ 117,000 |
| 50 lots | 10,000 | HK$ 130,000 |
| 100 lots | 20,000 | HK$ 260,000 |
| 150 lots | 30,000 | HK$ 390,000 |
| 200 lots | 40,000 | HK$ 520,000 |
| 250 lots | 50,000 | HK$ 650,000 |
| 300 lots | 60,000 | HK$ 780,000 |
| 350 lots | 70,000 | HK$ 910,000 |
| 400 lots | 80,000 | HK$ 1,040,000 |
| 450 lots | 90,000 | HK$ 1,170,000 |
| 500 lots | 100,000 | HK$ 1,300,000 |
| 750 lots | 150,000 | HK$ 1,950,000 |
| 1,000 lots | 200,000 | HK$ 2,600,000 |
| 1,250 lots | 250,000 | HK$ 3,250,000 |
| 1,500 lots | 300,000 | HK$ 3,900,000 |
| 1,750 lots | 350,000 | HK$ 4,550,000 |
Pool B
| Lots Subscribed | Shares Subscribed | Subscription Amount (HKD) |
|---|---|---|
| 2,000 lots | 400,000 | HK$ 5,200,000 |
| 2,250 lots | 450,000 | HK$ 5,850,000 |
| 2,500 lots | 500,000 | HK$ 6,500,000 |
| 3,000 lots | 600,000 | HK$ 7,800,000 |
| 3,500 lots | 700,000 | HK$ 9,100,000 |
| 4,000 lots | 800,000 | HK$ 10,400,000 |
| 4,500 lots | 900,000 | HK$ 11,700,000 |
| 5,000 lots | 1,000,000 | HK$ 13,000,000 |
| 5,604 lots | 1,120,800 | HK$ 14,570,400 |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | To be extracted |
| P/E Ratio | To be extracted |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | HK$ 9.2 |
|---|---|
| First Day Open | HK$ 11.24 |
| First Day Change | -29.23% |
| First Day Volume | 16319600.0 |
| First Day Turnover | 171030000.0 |
Use of Proceeds
| Use of Proceeds | 1、約35%或65.0百萬港元將用于優化并升級TrialOS平臺及PharmaOS平臺及其 各自的云端軟件及數字化服務； 2、約30%或約55.7百萬港元將用于提升核心技術及研發能力； 3、約10%或18.6百萬港元將用于強化銷售及營銷能力； 4、約15%或27.9百萬港元將用于選擇性地尋求認為將能擴充現有產品及服務品類、擴大客戶基礎及提升技術能力的戰略投資及收購； 5、約10%或18.6百萬港元將用作營運資金及一般企業用途。 |
|---|
Underwriting Syndicate
Joint Sponsors (2)
摩根士丹利亚洲有限公司 CE AAD291
中国国际金融香港证券有限公司 CE AEN894
Overall Coordinators (2)
摩根士丹利亚洲有限公司 CE AAD291
中国国际金融香港证券有限公司 CE AEN894
Joint Bookrunners (8)
摩根士丹利亚洲有限公司 CE AAD291
中国国际金融香港证券有限公司 CE AEN894
华泰金融控股（香港）有限公司 CE AOK809
招银国际融资有限公司 CE AVM940
建银国际金融有限公司 CE AJO225
富途证券国际（香港）有限公司 CE AZT137
老虎证券（香港）环球有限公司 CE BMU940
华盛资本证券有限公司 CE AUL711
Joint Lead Managers (8)
摩根士丹利亚洲有限公司 CE AAD291
中国国际金融香港证券有限公司 CE AEN894
华泰金融控股（香港）有限公司 CE AOK809
招银国际融资有限公司 CE AVM940
建银国际金融有限公司 CE AJO225
富途证券国际（香港）有限公司 CE AZT137
老虎证券（香港）环球有限公司 CE BMU940
华盛资本证券有限公司 CE AUL711
Cornerstone Investors
This stock has no cornerstone investors.
Directors & Management
| Chairman | 趙璐 |
|---|---|
| Company Secretary | 倪曉梅,潘秉揚 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 趙璐(16.60%),林芝騰訊投資管理有限公司(10.01%),經緯創騰(杭州)創業投資合伙企業(有限合伙)(9.00%) |
|---|
Subscription Tiers
IPO Timeline
